Evidence map›Paper›PMID 37892031›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity.

Marta González-Sierra, Alejandro Romo-Cordero, Juan Carlos Quevedo-Abeledo, Adrián Quevedo-Rodríguez, Fuensanta Gómez-Bernal, Antonia de Vera-González, Raquel López-Mejías, Candelaria Martín-González, Miguel Ángel González-Gay, Iván Ferraz-Amaro

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Marta González-SierraDivision of Hospitalization-at-Home, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Alejandro Romo-CorderoDivision of Internal Medicine, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Juan Carlos Quevedo-AbeledoDivision of Rheumatology, Hospital Universitario Dr. Negrín, 35010 Las Palmas de Gran Canaria, Spain.ORCID 0000-0003-0398-9072
Adrián Quevedo-RodríguezDivision of Rheumatology, Hospital Universitario Dr. Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Fuensanta Gómez-BernalDivision of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.ORCID 0000-0002-8597-1943
Antonia de Vera-GonzálezDivision of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Raquel López-MejíasEpidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL), 39011 Santander, Spain.ORCID 0000-0003-0548-2689
Candelaria Martín-GonzálezDivision of Internal Medicine, Hospital Universitario de Canarias, 38320 Tenerife, Spain.ORCID 0000-0002-4702-1840
Miguel Ángel González-GayDepartment of Medicine and Psychiatry, Universidad de Cantabria, 39005 Santander, Spain.ORCID 0000-0002-7924-7406
Iván Ferraz-AmaroInternal Medicine Department, Universidad de La Laguna, 38200 Tenerife, Spain.ORCID 0000-0003-0197-5267
Hospital Universitario de Canarias · ESHospital Universitario de Gran Canaria Doctor Negrín · ESUniversidad de La Laguna · ESInstituto de Investigación Marqués de Valdecilla · ESUniversidad de Cantabria · ES

Funding

Instituto de Salud Carlos III PI20/00084
6 · The paper itself

Abstract

Mean platelet volume (MPV) refers to the average platelet size in femtoliters. Increased or decreased MPV has been associated with several disorders, including inflammatory and cardiovascular diseases. In the present study, our objective was to analyze the relationship of MPV with disease activity in a large and well-characterized series of patients with rheumatoid arthritis (RA). This is a cross-sectional study that included 315 patients with RA and 208 controls matched by sex and age. Complete blood count, including MPV, was assessed. Multivariable analysis was performed to examine the relationship of MPV with RA disease characteristics, carotid atherosclerosis, and traditional cardiovascular factors, including a comprehensive profile of lipid molecules and insulin resistance or beta cell function indices. The multivariable analysis, which includes other hematological modifications produced by the disease and platelet values, showed that MPV levels were significantly lower in RA patients than in controls. Erythrocyte sedimentation rate and interleukin-6, but not C-reactive protein, were negatively correlated with MPV after adjustment for covariates. Similarly, disease activity and MPV had a significant and independent negative correlation. No relationships were found between MPV and cardiovascular risk factors, lipid profile or insulin resistance indices or subclinical atherosclerosis. In conclusion, patients with RA have lower levels of MPV than controls. MPV is negatively related to acute phase reactants and disease activity in RA.

Indexed as

cardiovascular diseasemean platelet volumerheumatoid arthritis

Identifiers

PMID37892031
PMCPMC10605652
OpenAlexW4387638882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.